News
Novo Nordisk , looking to turn around slowing growth of its blockbuster weight-loss drug Wegovy, plans to test whether its ...
Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, ...
The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback